AzTrials
AzTrials

StrokeNCT03508037

Therapy to Improve Reaching Movement in Upper Limb

A study testing Neuromodulation electroencephalographic signals and functional electrical stimulation based in people with Stroke and Impairment Upper Limb, run by Cajal Institute of the Spanish National Research Council at 1 site in Spain.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Strokes are caused by a bleed in the brain and can be life threatening. One common consequence is upper limb impairment. This causes stroke patients to be unable to use their arms and upper body to do simple tasks such as reaching or grasping. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Stroke, Impairment Upper Limb
What is being tested?
Neuromodulation electroencephalographic signals and functional electrical stimulation based
Could I receive a placebo?
No, everyone receives an active treatment
How many people
16 participants
Where
1 siteSpain
Study dates
12 Mar 2018to May 2019
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • With response to Transcranial Magnetic Stimulation (TMS)
  • Cortical or sub-cortical stroke patients
  • With a score in the range of 22-44 on Fugl-Meyer scale or 2-4 on the Motor Assessment Scale
  • With visible cortical patterns registered by BCI
  • Subjects that tolerate electrical stimulation and that present a motor response
  • Subjects with cognitive ability to follow instructions and perform the indicated tasks

Who cannot join

  • Subjects with neurological injury prior to stroke or more than two events
  • Patients with implanted devices
  • Patients with severe motor paralysis
  • Patients with epilepsy
  • Patient with vision or hearing impairment

Trial locations and contacts

1 site in 1 country.

Spain1 site, 1 recruiting
  • Centro de Referencia Estatal de Atención al Daño Cerebral (CEADAC)

    Madrid, 28034

    Carlos Gonzalez, +34 696993123, cgonzaalted@imserso.es

    Recruiting

Other trials in Spain

About this study

Official title: Hybrid Robotic System and EEG Based on an Adaptative and Associative Assistance for Rehabilitation of Reaching Movements After Stroke

Strokes are caused by a bleed in the brain and can be life threatening. One common consequence is upper limb impairment. This causes stroke patients to be unable to use their arms and upper body to do simple tasks such as reaching or grasping. Currently, people with stroke undergo rehabilitation, which is usually done through a physical and occupational (daily living skills) therapies to improve their mobility (movement) with their upper limbs. However, this kind of treatment has limitations and often cannot help patients regain total mobility. There are alternative rehabilitation treatments that use new methods and technologies that may be able to help patients with stroke. Neuromodulaton therapies using brain-computer interfaces (BCI), which connects brain signals directly to a computer, have the potential to help patients. This type of therapy uses assistive devices such as electrical stimulation (electrical shocks or waves) and robots to help restore function to the areas affected by stroke. The aim of this study is to evaluate and the potential benefits that can be achieved by using assistive devices in rehabilitation sessions with stroke patients.

Being tested
Neuromodulation electroencephalographic signals and functional electrical stimulation based
Medical subject headings
Stroke

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Neuromodulation electroencephalographic signals and functional electrical stimulation basedOther

    Also called Neuromodulation

    First, the subject performs twenty reaching movements without assistance with the damaged arm resting on a robot (ArmeoSpring), with the aim of finding the Contingent Negative Variation (CNV). Then, he or she executes five courses of twenty movements receiving functional electrical stimulation (FES), either at the moment in which he or she wishes to move (experimental group), or half a second before or after (control group).

Study groups in NCT03508037
Study groupRoleWhat they receive
Experimental groupExperimentalThe subject receives the Functional Electrical Stimulation (FES) when he or she has the intention to move. It is obtained through electroencephalography.
Receives: Other: Neuromodulation electroencephalographic signals and functional electrical stimulation based
Control groupActive comparatorThe subject receives the Functional Electrical Stimulation (FES) after o before (0.5 seconds) when he or she has the intention to move. It is obtained through electroencephalography.
Receives: Other: Neuromodulation electroencephalographic signals and functional electrical stimulation based

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Changes in muscular balance's of upper limb

    The function of muscle strength testing is to evaluate the complaint of weakness, often when there is a suspected neurologic disease. It is an integral part of the neurologic exam, especially for patients with stroke, brain injury, and others neurologic problems.

    The most commonly accepted method of evaluating muscle strength is the Medical Research Council Manual Muscle Testing scale. This method involves testing key muscles from the upper and lower extremities against the examiner's resistance and grading the patient's strength on a 0 to 5 scale accordingly:

    0 No muscle activation

    1. Trace muscle activation, such as a twitch, without achieving full range of motion
    2. Muscle activation with gravity eliminated, achieving full range of motion
    3. Muscle activation against gravity, full range of motion
    4. Muscle activation against some resistance, full range of motion
    5. Muscle activation against examiner's full resistance, full range of motion

    Measured: One week before the intervention. One week after the intervention. One month after the intervention. (The duration of the intervention is three weeks).

  2. Changes in modified scale of Answorth

    Modified Ashworth Scale tests resistance to passive movement about a joint with varying degrees of velocity. Scores range from 0-4, with 6 choices. A score of 1 indicates no resistance, and 6 indicates rigidity.

    Modified Ashworth Scale Scores:

    0 (0) - No increase in muscle tone

    1 (1) - Slight increase in muscle tone, manifested by a catch and release or by minimal resistance at the end of the range of motion when the affected part(s) is moved in flexion or extension.

    1+ (2) - Slight increase in muscle tone, manifested by a catch, followed by minimal resistance throughout the remainder (less than half) of the ROM (range of movement).

    2 (3) - More marked increase in musce tone through most of the ROM, but affect part(s) easily moved.

    3 (4) - Considerable increase in muscle tone passive, movement difficult 4 (5) - Affected part(s) rigid in flexion or extension

    Measured: One week before the intervention. One week after the intervention. One month after the intervention.

  3. Changes in FIM

    Provides a uniform system of measurement for disability based on the International Classification of Impairment, Disabilities and Handicaps; measures the level of a patient's disability and indicates how much assistance is required for the individual to carry out activities of daily living. Contains 18 items composed of:

    1. 13 motor tasks
    2. 5 cognitive tasks (considered basic activities of daily living) Tasks are rated on a 7-point ordinal scale that ranges from total assistance (or complete dependence) to complete independence.

    Scores range from 18 (lowest) to 126 (highest) indicating level of function.

    Dimensions assessed include:

    1. Eating
    2. Grooming
    3. Bathing
    4. Upper body dressing
    5. Lower body dressing
    6. Toileting
    7. Bladder management
    8. Bowel management
    9. Bed to chair transfer
    10. Toilet transfer
    11. Shower transfer
    12. Locomotion (ambulatory or wheelchair level)
    13. Stairs
    14. Cognitive comprehension
    15. Expression
    16. Social interaction
    17. Problem

    Measured: One week before the intervention. One week after the intervention. One month after the intervention.

  4. Changes in Quick Dash

    Assessment of symptoms and functionality in upper limb's pathology.

    Measured: One week before the intervention. One week after the intervention. One month after the intervention.

  5. Changes in Action Research Arm Test (ARAT)

    Assessment of coordination and manipulative skills in tasks of grasping and reaching objects.

    The ARAT's is a 19 item measure divided into 4 sub-tests (grasp, grip, pinch, and gross arm movement). Performance on each item is rated on a 4-point ordinal scale ranging from:

    1. Performs test normally 2) Completes test, but takes abnormally long or has great difficulty
    2. Performs test partially 0) Can perform no part of test

    Lyle's decision rules:

    1. Patients who achieve a maximum score on the first (most difficult) item are credited with having scored 3 on all subsequent items on that scale.
    2. If the patient scores less than 3 on the first item, then the second item is assessed.
    3. This is the easiest item, and if patients score 0 then they are unlikely to achieve a score above 0 for the remainder of the items and are credited with a zero for the other items.
    4. The maximum score on the ARTS is 57 points (possible range 0 to 57).

    Measured: One week before the intervention. One week after the intervention. One month after the intervention.

  6. Changes in Quebec User Evaluation of Satisfaction with Assistive Technology (QTEST)

    The Quebec User Evaluation of Satisfaction with assistive Technology (QUEST) was designed to measure the level of satisfaction attribute to assistive technologies. It does so using 27 variables which are scored in terms of perceived importance and satisfaction.

    For each of the 12 items, rate your satisfaction with your assistive device and the related services you experienced by using the following scale of 1 to 5.

    For each of the 12 items, the user has to rate their satisfaction with the assistive device and the related services their experienced by using the following scale of 1 to 5.

    1 - Not satisfied at all. 2- Not very satisfied. 3 - More or less satisfied. 4 - Quite satisfied. 5 -Very satisfied.

    Measured: One week before the intervention. One week after the intervention. One month after the intervention.

  7. Changes in the Self-Assessment Manikin (SAM)

    To assess the emotional response of user to different stimulus.

    Measured: One week before the intervention. One week after the intervention. One month after the intervention.

  8. Changes in isometric force

    To evaluate the isometric strength of the patient

    Measured: One week before the intervention. One week after the intervention. One month after the intervention.

  9. Changes in range of movement

    To evaluate the range of movement performed by the patient

    Measured: One week before the intervention. One week after the intervention. One month after the intervention.

  10. Changes in Lawton & Brody

    Assessment basic and instrumental activities of daily life. It evaluates the following categories and subcategories. For each of the latest, the subject has to circle the item description that most closely resembles their highest functional level (either 0 or 1): A. Ability to Use Telephone; B. Shopping; C.Food Preparation; D.Housekeeping; E. Laundry; F. Mode of Transportation; G. Responsibility for Own Medications; H. Ability to Handle Finances.

    Measured: One week before the intervention. One week after the intervention. One month after the intervention.

  11. Changes in Box and Block

    The Box and Block Test assesses unilateral gross manual dexterity. Individuals are seated at a table, facing a rectangular box that is divided into two square compartments of equal dimension by means of a partition. One hundred and fifty, 2.5 cm, colored, wooden cubes or blocks are placed in one compartment or the other. The individual is instructed to move as many blocks as possible, one at a time, from one compartment to the other for a period of 60 seconds. The BBT is scored by counting the number of blocks carried over the partition from one compartment to the other during the one-minute trial period. Patient's hand must cross over the partition in order for a point to be given, and blocks that drop or bounce out of the second.

    Measured: One week before the intervention. One week after the intervention. One month after the intervention.

  12. Changes in System Usability Scale (SUS)

    The System Usability Scale (SUS) provides a "quick and dirty", reliable tool for measuring the usability. It consists of a 10 item questionnaire with five response options for respondents; from Strongly agree to Strongly disagree.

    When a SUS is used, participants are asked to score the following 10 items with one of five responses that range from Strongly Agree to Strongly disagree:

    I think that I would like to use this system frequently. I found the system unnecessarily complex. I thought the system was easy to use. I think that I would need the support of a technical person to be able to use this system.

    I found the various functions in this system were well integrated. I thought there was too much inconsistency in this system. I would imagine that most people would learn to use this system very quickly. I found the system very cumbersome to use. I felt very confident using the system. I needed to learn a lot of things before I could get going with this system.

    Measured: One week before the intervention. One week after the intervention. One month after the intervention.

Secondary outcomes (1)
  1. Changes in Motor Evoked Potentials (MEPs).

    To assess the motor evoked potential.

    Measured: One week before the intervention. One week after the intervention. One month after the intervention.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted25 Apr 2018
  2. Study start12 Mar 2018
  3. Primary completion16 Feb 2019 (estimated)
  4. Study completionMay 2019 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Non-randomised
Intervention model
Parallel groups
Masking
Triple blind
Who is masked
Participant, Care provider, Outcomes assessor
Enrolment
16 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03508037
Sponsor's protocol ID
CSEULS-PI-106/2016
Status last verified
Apr 2018
First submitted
22 Mar 2018
Last updated
21 Sep 2018
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

A study testing Neuromodulation electroencephalographic signals and functional electrical stimulation based in people with Stroke and Impairment Upper Limb, run by Cajal Institute of the Spanish National Research Council at 1 site in Spain.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 21 Sep 2018. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Spain. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Oscar Herrero (+ 34 645 16 31 66, oscar.herrero@cajal.csic.es), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Changes in muscular balance's of upper limb (time frame: One week before the intervention. One week after the intervention. One month after the intervention. (The duration of the intervention is three weeks).). The study lists 12 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 Sep 2018; AzTrials last refreshed its copy on 3 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in